These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 8390996)

  • 1. Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression.
    Monia BP; Lesnik EA; Gonzalez C; Lima WF; McGee D; Guinosso CJ; Kawasaki AM; Cook PD; Freier SM
    J Biol Chem; 1993 Jul; 268(19):14514-22. PubMed ID: 8390996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids.
    Lima WF; Crooke ST
    Biochemistry; 1997 Jan; 36(2):390-8. PubMed ID: 9003192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets.
    Kawasaki AM; Casper MD; Freier SM; Lesnik EA; Zounes MC; Cummins LL; Gonzalez C; Cook PD
    J Med Chem; 1993 Apr; 36(7):831-41. PubMed ID: 8464037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
    Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
    Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras.
    Monia BP; Johnston JF; Sasmor H; Cummins LL
    J Biol Chem; 1996 Jun; 271(24):14533-40. PubMed ID: 8662854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides.
    Moulds C; Lewis JG; Froehler BC; Grant D; Huang T; Milligan JF; Matteucci MD; Wagner RW
    Biochemistry; 1995 Apr; 34(15):5044-53. PubMed ID: 7536034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
    Gao WY; Han FS; Storm C; Egan W; Cheng YC
    Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides.
    Monia BP; Johnston JF; Ecker DJ; Zounes MA; Lima WF; Freier SM
    J Biol Chem; 1992 Oct; 267(28):19954-62. PubMed ID: 1400312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of antisense oligonucleotides stabilized by locked nucleic acids.
    Kurreck J; Wyszko E; Gillen C; Erdmann VA
    Nucleic Acids Res; 2002 May; 30(9):1911-8. PubMed ID: 11972327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorothioate oligonucleotides block reverse transcription by the Rnase H activity associated with the HIV-1 polymerase.
    Hatta T; Takai K; Yokoyama S; Nakashima H; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1995 Jun; 211(3):1041-6. PubMed ID: 7541196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-beta-D-erythro-hexopyranosyl nucleosides.
    Augustyns K; Godard G; Hendrix C; Van Aerschot A; Rozenski J; Saison-Behmoaras T; Herdewijn P
    Nucleic Acids Res; 1993 Oct; 21(20):4670-6. PubMed ID: 7694231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes.
    Hanecak R; Brown-Driver V; Fox MC; Azad RF; Furusako S; Nozaki C; Ford C; Sasmor H; Anderson KP
    J Virol; 1996 Aug; 70(8):5203-12. PubMed ID: 8764029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexes.
    Crooke ST; Lemonidis KM; Neilson L; Griffey R; Lesnik EA; Monia BP
    Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):599-608. PubMed ID: 8526876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense properties of end-modified oligonucleotides targeted to Ha-ras oncogene.
    Saison-Behmoaras TE; Duroux I; Nguyen TT; Asseline U; Hélène C
    Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):361-8. PubMed ID: 9303188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides.
    Brown-Driver V; Eto T; Lesnik E; Anderson KP; Hanecak RC
    Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):145-54. PubMed ID: 10355821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms.
    Chiang MY; Chan H; Zounes MA; Freier SM; Lima WF; Bennett CF
    J Biol Chem; 1991 Sep; 266(27):18162-71. PubMed ID: 1680858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo.
    Prakash TP; Johnston JF; Graham MJ; Condon TP; Manoharan M
    Nucleic Acids Res; 2004; 32(2):828-33. PubMed ID: 14762210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of point mutation-selective antisense DNA targeted to codon 12 of Ha-ras mRNA in human cells.
    Duroux I; Godard G; Boidot-Forget M; Schwab G; Hélène C; Saison-Behmoaras T
    Nucleic Acids Res; 1995 Sep; 23(17):3411-8. PubMed ID: 7567450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA.
    Bruice TW; Lima WF
    Biochemistry; 1997 Apr; 36(16):5004-19. PubMed ID: 9125523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antisense oligonucleotides comprising 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (FANA): specificity, potency, and duration of activity.
    Ferrari N; Bergeron D; Tedeschi AL; Mangos MM; Paquet L; Renzi PM; Damha MJ
    Ann N Y Acad Sci; 2006 Oct; 1082():91-102. PubMed ID: 17145930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.